Sign In

Mary Fisher

Life Sciences CEO, Entrepreneur and Corporate Director

Professional Background

Mary Fisher is an accomplished executive in the pharmaceutical and biotechnology sectors, bringing over 25 years of extensive experience to the table. As the Chief Executive Officer and Director at Colorescience, she has successfully led the company through transformative strategies in the dermatological field. Fisher’s leadership qualities are further highlighted by her previous role as the Chief Executive Officer at SkinMedica, Inc., where she played a pivotal role in the successful sale of the company to Allergan, Inc. for an impressive $375 million in 2012. This transaction not only marked a significant achievement in her career but also showcased her value in driving high-stakes negotiations and securing favorable outcomes for her organizations.

Prior to her tenure at SkinMedica, Fisher served as the Chief Operating Officer at Acorda Therapeutics, where she was instrumental in orchestrating a major restructuring and spearheading the company’s initial public offering. Her strategic insights were critical during a pivotal time for Acorda, ensuring its transition from a developmental business model to a successful commercial enterprise. Additionally, she was involved in a substantial $50 million acquisition that further solidified the company’s place within the biotechnology landscape.

Education and Achievements

Mary Fisher graduated with a degree that set the foundation for her impactful career in the healthcare and pharmaceutical industries. Throughout her professional journey, she has developed a reputation for excellence in commercialization strategies, resource planning, and market expansion initiatives. Her expertise encompasses a wide array of specialties, including pricing strategy, distribution planning, managed care contracting, and forecasting; these skills enable her to navigate complex market dynamics while positioning her companies for sustained growth.

Beyond her executive roles, Fisher has also taken on consulting positions for leading firms such as Acorda Therapeutics and Roche Diagnostics. These experiences have allowed her to apply her extensive knowledge to diverse organizational challenges, enhancing the commercial success of the companies she has supported.

Fisher's passion for promoting health and wellness is evident through her active engagement in various organizations. She currently serves as a committed board member for both Zeltiq and OvaScience, in addition to her contributions to the Neuroscience Nursing Foundation. These board memberships illustrate her dedication to advancing healthcare solutions and supporting interdisciplinary collaboration within the medical community. Her involvement with notable professional organizations, including the Women’s Dermatological Society and the Dermatology Foundation Leader’s Society, underlines her commitment to fostering leadership opportunities for women in health-related fields.

Achievements

Mary Fisher's career is marked by numerous achievements that exemplify her exceptional leadership and strategic capabilities. Not only has she successfully directed multiple companies toward lucrative exits, but her track record also highlights her ability to adapt to changing industry landscapes. Under her guidance, Colorescience has flourished, further establishing itself as a leader in skincare and enhancing its market reputation.

Additionally, Fisher's role in the reshaping of Acorda Therapeutics influenced the broader biotechnology sector. By facilitating the company’s scaling efforts, she has contributed meaningfully to the advancement of treatments for central nervous system disorders. Through her initiatives in commercialization and strategic healthcare operations, she has played a crucial role in bringing innovative solutions to the market.

Given her wealth of experience, Fisher also serves as a mentor to many aspiring professionals in the healthcare and biotechnology industries. Her influence extends beyond her immediate roles, inspiring a new generation of female leaders to pursue careers in fields that contribute to public health and the advancement of medical sciences. Her proactive engagement in mentorship programs and professional societies showcases her commitment to nurturing talent and promoting diversity within the workplace.

In summary, Mary Fisher is a dynamic leader with a profound impact on the fields of pharmaceuticals and biotechnology. Her strategic vision and ability to navigate complex business environments have not only earned her recognition but have also ensured the success of the organizations she leads. As she continues to advocate for innovation and excellence in healthcare, her legacy as a transformative figure in the industry is firmly established.

Related Questions

How did Mary Fisher develop her extensive expertise in the pharmaceutical and biotechnology industries?
What strategies did Mary Fisher employ to lead Colorescience and ensure its continued success?
How has Mary Fisher’s experience at Acorda Therapeutics influenced her leadership methods at Colorescience?
In what ways does Mary Fisher contribute to mentoring aspiring leaders in the healthcare sector?
What significant challenges did Mary Fisher face during her tenure as CEO at SkinMedica, and how did she overcome them?
How does Mary Fisher advocate for women's leadership opportunities within the pharmaceutical and biotechnology industries?
Mary Fisher
Add to my network

Location

Carlsbad, California, United States